126 related articles for article (PubMed ID: 10574952)
1. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein.
Bosilevac JM; Olsen RJ; Bridge JA; Hinrichs SH
J Biol Chem; 1999 Dec; 274(49):34811-8. PubMed ID: 10574952
[TBL] [Abstract][Full Text] [Related]
2. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
Li KK; Goodall J; Goding CR; Liao SK; Wang CH; Lin YC; Hiraga H; Nojima T; Nagashima K; Schaefer KL; Lee KA
Br J Cancer; 2003 Sep; 89(6):1072-8. PubMed ID: 12966428
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
[TBL] [Abstract][Full Text] [Related]
5. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription.
Li KK; Lee KA
Oncogene; 1998 Mar; 16(10):1325-31. PubMed ID: 9546434
[TBL] [Abstract][Full Text] [Related]
6. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
[TBL] [Abstract][Full Text] [Related]
7. Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.
Komura S; Ito K; Ohta S; Ukai T; Kabata M; Itakura F; Semi K; Matsuda Y; Hashimoto K; Shibata H; Sone M; Jo N; Sekiguchi K; Ohno T; Akiyama H; Shimizu K; Woltjen K; Ozawa M; Toguchida J; Yamamoto T; Yamada Y
Nat Commun; 2019 Sep; 10(1):3999. PubMed ID: 31488818
[TBL] [Abstract][Full Text] [Related]
8. EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.
Yamada K; Ohno T; Aoki H; Semi K; Watanabe A; Moritake H; Shiozawa S; Kunisada T; Kobayashi Y; Toguchida J; Shimizu K; Hara A; Yamada Y
J Clin Invest; 2013 Feb; 123(2):600-10. PubMed ID: 23281395
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins.
Olsen RJ; Hinrichs SH
Oncogene; 2001 Mar; 20(14):1756-64. PubMed ID: 11313922
[TBL] [Abstract][Full Text] [Related]
10. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
Antonescu CR; Nafa K; Segal NH; Dal Cin P; Ladanyi M
Clin Cancer Res; 2006 Sep; 12(18):5356-62. PubMed ID: 17000668
[TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma.
Li BX; David LL; Davis LE; Xiao X
J Biol Chem; 2022 Oct; 298(10):102434. PubMed ID: 36041632
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.
Davis IJ; Kim JJ; Ozsolak F; Widlund HR; Rozenblatt-Rosen O; Granter SR; Du J; Fletcher JA; Denny CT; Lessnick SL; Linehan WM; Kung AL; Fisher DE
Cancer Cell; 2006 Jun; 9(6):473-84. PubMed ID: 16766266
[TBL] [Abstract][Full Text] [Related]
13. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
Coindre JM; Hostein I; Terrier P; Bouvier-Labit C; Collin F; Michels JJ; Trassard M; Marques B; Ranchere D; Guillou L
Cancer; 2006 Sep; 107(5):1055-64. PubMed ID: 16878328
[TBL] [Abstract][Full Text] [Related]
15. Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo.
Aryee DN; Kreppel M; Bachmaier R; Uren A; Muehlbacher K; Wagner S; Breiteneder H; Ban J; Toretsky JA; Kovar H
Cancer Res; 2006 Oct; 66(20):9862-9. PubMed ID: 17047047
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
Outani H; Tanaka T; Wakamatsu T; Imura Y; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
BMC Cancer; 2014 Jun; 14():455. PubMed ID: 24946937
[TBL] [Abstract][Full Text] [Related]
17. Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma.
Davis IJ; McFadden AW; Zhang Y; Coxon A; Burgess TL; Wagner AJ; Fisher DE
Cancer Res; 2010 Jan; 70(2):639-45. PubMed ID: 20068147
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.
Liu S; Cheng H; Kwan W; Lubieniecka JM; Nielsen TO
Mol Cancer Ther; 2008 Jun; 7(6):1751-61. PubMed ID: 18566246
[TBL] [Abstract][Full Text] [Related]
19. Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.
Hakozaki M; Tamura H; Dobashi Y; Yoshida A; Kato K; Tajino T; Yamada H; Kaneuchi Y; Katahira K; Ezaki J; Waguri S; Konno S; Watanabe S
Anticancer Res; 2018 Sep; 38(9):5035-5042. PubMed ID: 30194147
[TBL] [Abstract][Full Text] [Related]
20. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.
Brown AD; Lopez-Terrada D; Denny C; Lee KA
Oncogene; 1995 May; 10(9):1749-56. PubMed ID: 7753552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
